3,346
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Angiotensin II-induced vascular endothelial cells ferroptosis via P53-ALOX12 signal axis

, , , &
Article: 2180019 | Received 01 Sep 2022, Accepted 08 Feb 2023, Published online: 01 Mar 2023

References

  • Bo C, Ning K, Delin C, Tong-Yuan L, Tong L, Le J, Shu-Juan S, Omid T, Wei G. ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21:579–7. doi:10.1038/s41556-019-0305-6.
  • Jie L, Feng C, He-Liang Y, Zi-Jian H, Zhi-Tao L, Ning M, Bei S, Gang W. Ferroptosis: past, present and future. Cell Death Dis. 2020;11:1–13. doi:10.1038/s41419-020-2298-2.
  • Kang R, Kroemer G, Tang D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic Biol Med. 2019;133:162–68. doi:10.1016/j.freeradbiomed.2018.05.074.
  • Shi ZZ, Fan Z-W, Chen Y-X, Xie X-F, Jiang W, Wang W-J, Qiu Y-T, Bai J. Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy. Onco Targets Ther. 2019;12:11291–304. doi:10.2147/OTT.S232852.
  • Hernanz R, Martínez-Revelles S, Palacios R, Martín A, Cachofeiro V, Aguado A, García-Redondo L, Barrús MT, de-Batista PR, Briones AM, et al. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension. Br J Pharmacol. 2015;172:3159–76. doi:10.1111/bph.13117.
  • Miao-Qian S, Fei-Fei S, Xuan X, Xiong-Tao L, Hong-Tao W, Wei Z, Xue L, Cheng L, Qiang-Sun Z, Zhi-Chun F. Cilostazol suppresses angiotensin II‑induced apoptosis in endothelial cells. Mol Med Rep. 2016;13:2597–605. doi:10.3892/mmr.2016.4881.
  • Chuan-Zhao J, Yang Y, Min Z, Wenyan Y, Shuo D. Loxoprofen sodium alleviates oxidative stress and apoptosis induced by angiotensin II in Human Umbilical Vein Endothelial Cells (HUVECs). Drug Des Devel Ther. 2020;14:5087–96. doi:10.2147/DDDT.S266175.
  • Gnanapradeepan K, Basu S, Barnoud T, Budina-Kolomets A, Kung CP, Murphy ME. The p53 tumor suppressor in the control of metabolism and ferroptosis. Front Endocrinol. 2018;9:1–7. doi:10.3389/fendo.2018.00124.
  • Wei-Fen Z, Cheng-Cheng A, Dejun G, Fang D, Wen-Tong W. Targeted p53 on small-molecules-induced ferroptosis in cancers. Front Oncol. 2018;8:1–9. doi:10.3389/fonc.2018.00507.
  • Dong C, Liu S, Cui Y, Guo Q. 12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy. Eur J Pharmacol. 2020;879:1–12. doi:10.1016/j.ejphar.2020.173122.
  • Zhong-hua Z, Yin L, Gehui J, Tianyi H, Mengsha Z, Shiwei D. The biological role of arachidonic acid 12-lipoxygenase (ALOX12) in various human diseases. Biomed Pharmacother. 2020;129:1–11. doi:10.1016/j.biopha.2020.110354.
  • Siang-Jong L, Goldman DH, Kriska T, Gauthier KM, Smyth EM, Puli N, Kumar G, Falck JR, Campbell WB. Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries. Acta Physiol. 2017;219:188–201. doi:10.1111/apha.12642.
  • Young-Kim H, Won-Jeong D, Sun-Park H, Yoon-Lee T, Sun- Kim H. Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats. Hypertens Res. 2019;36:65–73. doi:10.1038/hr.2012.119.
  • Limor R, Kaplan M, Sharon O, Knoll E, Naidich M, Weisinger G, Keidar S, Stern N. Aldosterone up-regulates 12- and 15-li-poxygenase expression and LDL oxidation in human vascular smooth muscle cells. J Cell Biochem. 2009;108:1203–10. doi:10.1002/jcb.22352.